Prevalence of metabolic syndrome in bipolar patients initiating acute-phase treatment: A 6-month follow up

Psychiatry and Clinical Neurosciences

Volumn 64, Issue 6, 2010, Pages 625-633

  Guan, Nianhong ^a   Liu, Hairen ^a   Diao, Feici ^a   Zhang, Jinbei ^a   Zhang, Ming ^a   Wu, Tingjuan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

acute phase treatment; bipolar disorder; correlate; follow up; metabolic syndrome

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BIPOLAR DISORDER; CHINA; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; SYMPTOM; WEIGHT GAIN;

ADULT; BIPOLAR DISORDER; CHINA; DISEASE PROGRESSION; DYSLIPIDEMIAS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERGLYCEMIA; HYPERTENSION; MALE; METABOLIC SYNDROME X; OVERWEIGHT; PREVALENCE; RISK FACTORS;

EID: 78649669311     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2010.02150.x     Document Type: Article

References (37)

1. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C,. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-438.
2. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
3. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
4. Resnick HE, Jones K, Ruotolo G, et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: the Strong Heart Study. Diabetes Care 2003; 26: 861-867.
5. Sattar N, Gaw A, Scherbakova O, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108: 414-419.
6. Kurl S, Laukkanen JA, Niskanen L, et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 2006; 37: 806-811.
7. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary. Crit. Pathw. Cardiol. 2005; 4: 198-203.
8. Weng X, Liu Y, Ma J, Wang W, Yang G, Caballero B,. An urban-rural comparison of the prevalence of the metabolic syndrome in Eastern China. Public Health Nutr. 2007; 10: 131-136.
9. Li Y, Yang X, Zhai F, et al. Prevalence of the metabolic syndrome in Chinese adolescents. Br. J. Nutr. 2008; 99: 565-570.
10. Regenold WT, Thapar RK, Marano C, Gavirneni S, Kondapavuluru PV,. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J. Affect. Disord. 2002; 70: 19-26.
11. Fagiolini A, Kupfer DJ, Scott J, et al. Hypothyroidism in patients with bipolar I disorder treated primarily with lithium. Epidemiol. Psichiatr. Soc. 2006; 15: 123-127.
12. Walsh JP, Bremner AP, Bulsara MK, et al. Thyroid dysfunction and serum lipids: a community-based study. Clin. Endocrinol. (Oxf) 2005; 63: 670-675.
13. Watson S, Gallagher P, Ritchie JC, Ferrier IN, Young AH,. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br. J. Psychiatry 2004; 184: 496-502.
14. Taylor V, MacQueen G,. Associations between bipolar disorder and metabolic syndrome: a review. J. Clin. Psychiatry 2006; 67: 1034-1041.
15. Landsberg L,. Role of the sympathetic adrenal system in the pathogenesis of the insulin resistance syndrome. Ann. N. Y. Acad. Sci. 1999; 892: 84-90.
16. Wildes JE, Marcus MD, Fagiolini A,. Obesity in patients with bipolar disorder: a biopsychosocial-behavioral model. J. Clin. Psychiatry 2006; 67: 904-915. (Pubitemid 44049089)
17. Wildes JE, Marcus MD, Fagiolini A,. Prevalence and correlates of eating disorder co-morbidity in patients with bipolar disorder. Psychiatry Res. 2008; 161: 51-58.
18. Meyer JM,. A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year. J. Clin. Psychiatry 2002; 63: 425-433.
19. Guo JJ, Keck PE Jr, Corey-Lisle PK, et al. Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: a retrospective, population-based, case-control study. J. Clin. Psychiatry 2006; 67: 1055-1061.
20. Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ,. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord. 2005; 7: 424-430.
21. Cardenas J, Frye MA, Marusak SL, et al. Modal subcomponents of metabolic syndrome in patients with bipolar disorder. J. Affect. Disord. 2008; 106: 91-97.
22. Birkenaes AB, Opjordsmoen S, Brunborg C, et al. The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. J. Clin. Psychiatry 2007; 68: 917-923.
23. Garcia-Portilla MP, Saiz PA, Benabarre A, et al. The prevalence of metabolic syndrome in patients with bipolar disorder. J. Affect. Disord. 2008; 106: 197-201.
24. Chang HH, Chou CH, Chen PS, et al. High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan. J. Affect. Disord. 2009; 117: 124-129.
25. Yumru M, Savas HA, Kurt E, et al. Atypical antipsychotics related metabolic syndrome in bipolar patients. J. Affect. Disord. 2007; 98: 247-252.
26. Correll CU, Frederickson AM, Kane JM, Manu P,. Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics. Bipolar Disord. 2008; 10: 788-797.
27. Vestergaard P, Schou M,. Does long-term lithium treatment induce diabetes mellitus? Neuropsychobiology 1987; 17: 130-132.
28. Chang HH, Yang YK, Gean PW, Huang HC, Chen PS, Lu RB,. The role of valproate in metabolic disturbances in bipolar disorder patients. J. Affect. Disord. 2010; 124: 319-320.
29. Kim B, Kim SJ, Son JI, Joo YH,. Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients. J. Affect. Disord. 2008; 105: 45-52.
30. Lu YH, Lu JM, Wang SY, et al. [Comparison of the diagnostic criteria of metabolic syndrome by International Diabetes Federation and that by Chinese Medical Association Diabetes Branch]. Zhonghua Yi Xue Za Zhi 2006; 86: 386-389.
31. Hamilton M,. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960; 23: 56-62.
32. Bech P, Rafaelsen OJ, Kramp P, Bolwig TG,. The mania rating scale: scale construction and inter-observer agreement. Neuropharmacology 1978; 17: 430-431.
33. Cozzi Lepri A, Smith GD, Mocroft A, Sabin CA, Morris RW, Phillips AN,. A practical approach to adjusting for attrition bias in HIV clinical trials with serial marker responses. AIDS 1998; 12: 1155-1161.
34. O'Brien PC, Zhang D, Bailey KR,. Semi-parametric and non-parametric methods for clinical trials with incomplete data. Stat. Med. 2005; 24: 341-358.
35. Gu D, Reynolds K, Wu X, et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005; 365: 1398-1405.
36. Wang ZW, Wang X, Li X, et al. [Prevalence and trend of metabolic syndrome in middle-aged Chinese population]. Zhonghua Liu Xing Bing Xue Za Zhi 2009; 30: 596-600.
37. Kim B, Kim S, McIntyre RS, Park HJ, Kim SY, Joo YH,. Correlates of metabolic abnormalities in bipolar I disorder at initiation of acute phase treatment. Psychiatry Investig. 2009; 6: 78-84.